When temperature-controlled supply chain operations fail, patients experience delays in receiving important medications. Tom Hart, COO of BioCare, provides insight into some challenges related to cold supply chain maintenance and emphasizes keeping the well-being of individual...
Your success as a pharmaceutical company heavily relies on the implementation of a quality management system. With ever-changing FDA regulations and technological advancements, the demand for solid infrastructure with quality in mind is increasing. Truthfully, the...
The U.S. Food and Drug Administration (FDA) recently announced the proposed rule, which aims to create a uniform national licensing standard for wholesale distributors and third-party logistics providers (3PLs). Historically, states have set their own standards...
There are a variety of challenges that patients may face when accessing medication. In fact, a 2019 study on medication access identified 17 distinct barriers that patients must overcome, including costs, transportation, and geographical characteristics that...
With deep knowledge and expertise, delivering critically needed and life-saving therapies to patients with rare, ultra-rare, and orphan diseases is our next guest’s passion and mission in life. Jeff Beck, Chief Development Officer at Biocare, joins us...
With all the challenges facing the global supply chain in recent years, including materials and labor shortages, it comes as no surprise that third-party logistics (3PL) providers are looking to utilize cutting edge technologies to create...
Tom Hart, COO of BioCare, a specialty distributor of medications, discusses the ways to combat the cold chain-warmer temperatures dilemma, along with his future outlook on the industry supply chain as a whole.
BioCareSD, a specialty distributor of life-saving therapies, today announced a contract with UCB to add six new product offerings to its already diverse portfolio. This partnership, which will enable BioCareSD to service a wider patient population, demonstrates the organization’s continued...
Over the past 5 years, the FDA has approved an average of 51 novel drugs annually. As a manufacturer prepares to bring any new drug to market, there are several important decisions to be made along...
The popular saying, “the only constant is change,” may sound cliché, but it is invariably true. Change is largely unavoidable, a fact successful business leaders know all too well. Within a company, change occurs in a variety...
